Characterization of Clinical and Genetic Risk Factors Associated with Dyslipidemia after Kidney Transplantation
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
We determined the prevalence of dyslipidemia in a Japanese cohort of renal allograft recipients and investigated clinical and genetic characteristics associated with having the disease. In total, 126 patients that received renal allograft transplants between February 2002 and August 2011 were studied, of which 44 recipients (34.9%) were diagnosed with dyslipidemia at 1 year after transplantation. Three clinical factors were associated with a risk of having dyslipidemia: a higher prevalence of disease observed among female than male patientsP=0.021and treatment with high mycophenolate mofetilP=0.012and prednisoloneP=0.023doses per body weight at 28 days after transplantation. The genetic association between dyslipidemia and 60 previously described genetic polymorphisms in 38 putative disease-associated genes was analyzed. The frequency of dyslipidemia was significantly higher in patients with the glucocorticoid receptor (NR3C1)Bcl1 G allele than in those with the CC genotypeP=0.001. A multivariate analysis revealed that the NR3C1 Bcl1 G allele was a significant risk factor for the prevalence of dyslipidemia (odds ratio = 4.6; 95% confidence interval = 1.8–12.2). These findings may aid in predicting a patient’s risk of developing dyslipidemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Life-long high levels of LDL-C [476] and Lp(a) [477] have been associated with incident aortic valve stenosis and aortic valve calcification in genetic Mendelian randomization studies.”
From 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (2019) · cites this paper as [476]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cholesterol Treatment Trialists' (CTT) Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)61350-5 · Cited by 6,550
Kinoshita, M., Yokote, K., Arai, H., Iida, M., Ishigaki, Y., Ishibashi, S., Umemoto, S., Egusa, G., Ohmura, H., Okamura, T., et al. (2018) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.gl2017 · Cited by 813
Woodle, E. S., First, M. R., Pirsch, J., Shihab, F., Gaber, A. O., & Van Veldhuisen, P. (2008) · Annals of Surgery · doi:10.1097/sla.0b013e318187d1da · Cited by 474
Holdaas, H., Fellström, B., Cole, E., Nyberg, G., Olsson, A. G., Pedersen, T. R., Madsen, S., Grönhagen‐Riska, C., Neumayer, H. ‐., Maes, B., et al. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.01105.x · Cited by 343
Ekberg, H., Bernasconi, C., Tedesco-Silva, H., Vítko, S., Hugo, C., Demirbas, A., Reyes Acevedo, R., Grinyó, J., Frei, U., Vanrenterghem, Y., et al. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02726.x · Cited by 334
Kasiske, B., Cosio, F. G., Beto, J., Bolton, K., Chavers, B. M., Grimm, R., Levin, A., Masri, B., Parekh, R., Wanner, C., et al. (2004) · American Journal of Transplantation · doi:10.1111/j.1600-6135.2004.0355.x · Cited by 316
HYPERLIPIDEMIA IN SOLID ORGAN TRANSPLANTATION
Kobashigawa, J. A., & Kasiske, B. L. (1997) · Transplantation · doi:10.1097/00007890-199702150-00001 · Cited by 314
Okamura, T., Tsukamoto, K., Arai, H., Fujioka, Y., Ishigaki, Y., Koba, S., Ohmura, H., Shoji, T., Yokote, K., Yoshida, H., et al. (2024) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.gl2022 · Cited by 302
Rosmond, R., Chagnon, Y. C., Holm, G., Chagnon, M., Pérusse, L., Lindell, K., Carlsson, B., Bouchard, C., & Björntorp, P. (2000) · Obesity Research · doi:10.1038/oby.2000.24 · Cited by 247
Mammalian target of rapamycin inhibitor dyslipidemia in kidney transplant recipients
Kasiske, B. L., de Mattos, A., Flechner, S. M., Gallon, L., Meier-Kriesche, H.-U., Weir, M. R., & Wilkinson, A. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2008.02272.x · Cited by 163
Independent Effects of Cyclosporine and Prednisone on Posttransplant Hypercholesterolemia
Wick, D. E., Mayes, J. T., & Schulak, J. A. (1991) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80095-3 · Cited by 129
Numakura, K., Satoh, S., Tsuchiya, N., Horikawa, Y., Inoue, T., Kakinuma, H., Matsuura, S., Saito, M., Tada, H., Suzuki, T., et al. (2005) · Transplantation · doi:10.1097/01.tp.0000181142.82649.e3 · Cited by 96
Self-citationMiura, M., Kagaya, H., Satoh, S., Inoue, K., Saito, M., Habuchi, T., & Suzuki, T. (2008) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0b013e3181838063 · Cited by 91
Self-citationUse of Cardioprotective Medications in Kidney Transplant Recipients
Gaston, R. S., Kasiske, B. L., Fieberg, A. M., Leduc, R. E., Cosio, F., Gourishankar, S., Halloran, P. F., Hunsicker, L. G., Rush, D. N., & Matas, A. J. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02696.x · Cited by 85
Dyslipidemia and its therapeutic challenges in renal transplantation
Riella, L. V., Gabardi, S., & Chandraker, A. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2012.04084.x · Cited by 82 · cited 2×
“It is frequently observed in renal transplant recipients [1] and is a risk factor for cardiovascular disease and graft loss [2].”
BackgroundTakami, S., Imai, Y., Katsuya, T., Ohkubo, T., Tsuji, I., Nagai, K., Satoh, H., Hisamichi, S., Higaki, J., & Ogihara, T. (2000) · American Journal of Hypertension · doi:10.1016/s0895-7061(99)00184-3 · Cited by 82
Association of Common Variation in the HNF1α Gene Region With Risk of Type 2 Diabetes
Winckler, W., Burtt, N. P., Holmkvist, J., Cervin, C., de Bakker, P. I. W., Sun, M., Almgren, P., Tuomi, T., Gaudet, D., Hudson, T. J., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.8.2336 · Cited by 79
Clustering of metabolic abnormalities in obese individuals: the role of genetic factors
Ukkola, O., & Bouchard, C. (2001) · Annals of Medicine · doi:10.3109/07853890109002062 · Cited by 79
Weight Change and Serum Lipoproteins in Recipients of Renal Allografts
Gonyea, J., & Anderson, C. F. (1992) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)60720-4 · Cited by 66
Influence of drug-transporter polymorphisms on the pharmacokinetics of fexofenadine enantiomers
Akamine, Y., Miura, M., Sunagawa, S., Kagaya, H., Yasui‐Furukori, N., & Uno, T. (2010) · Xenobiotica · doi:10.3109/00498254.2010.515318 · Cited by 60
Self-citationSatoh, S., Saito, M., Inoue, T., Kagaya, H., Miura, M., Inoue, K., Komatsuda, A., Tsuchiya, N., Suzuki, T., & Habuchi, T. (2009) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-008-0606-3 · Cited by 54
Self-citationSatoh, S., Tada, H., Murakami, M., Tsuchiya, N., Li, Z., Numakura, K., Saito, M., Inoue, T., Miura, M., Hayase, Y., et al. (2006) · Transplantation · doi:10.1097/01.tp.0000231874.53240.ba · Cited by 49
Self-citationNumakura, K., Satoh, S., Tsuchiya, N., Saito, M., Maita, S., Obara, T., Tsuruta, H., Inoue, T., Narita, S., Horikawa, Y., et al. (2012) · Transplantation · doi:10.1097/tp.0b013e318254391b · Cited by 49
Self-citationRosmond, R., & Holm, G. (2008) · Journal of the CardioMetabolic Syndrome · doi:10.1111/j.1559-4572.2008.00008.x · Cited by 41
Motoyama, S., Miura, M., Hinai, Y., Maruyama, K., Usami, S., Saito, H., Minamiya, Y., Satoh, S., Murata, K., Suzuki, T., et al. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0525-2 · Cited by 35
Self-citationTsuzaki, K., Kotani, K., Sano, Y., Fujiwara, S., Takahashi, K., & Sakane, N. (2010) · BMC Medical Genetics · doi:10.1186/1471-2350-11-150 · Cited by 30
Miura, Y., Satoh, S., Saito, M., Numakura, K., Inoue, T., Obara, T., Tsuruta, H., Narita, S., Horikawa, Y., Tsuchiya, N., et al. (2010) · Transplantation · doi:10.1097/tp.0b013e3181ff4f7f · Cited by 29
Self-citationResponse to prednisone in relation to NR3C1 intron B polymorphisms in childhood nephrotic syndrome
Zalewski, G., Wasilewska, A. M., Zoch-Zwierz, W. M., & Chyczewski, L. (2008) · Pediatric Nephrology · doi:10.1007/s00467-008-0772-7 · Cited by 27
Fujiyama, N., Miura, M., Satoh, S., Inoue, K., Kagaya, H., Saito, M., Habuchi, T., & Suzuki, T. (2009) · Xenobiotica · doi:10.1080/00498250902807338 · Cited by 27
Self-citationSrivastava, N., Prakash, J., Lakhan, R., Agarwal, C., Pant, D., & Mittal, B. (2011) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-010-0099-6 · Cited by 23
Yamada (2009) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000226 · Cited by 23
Yan, Y., Dong, J., Wu, L., Shao, S., Zhang, J., Zhang, L., Wang, W., He, Y. L., & Liu, Y.-Q. (2013) · Journal of Epidemiology · doi:10.2188/jea.je20130035 · Cited by 22
Miura, M., Niioka, T., Kato, S., Kagaya, H., Saito, M., Habuchi, T., & Satoh, S. (2011) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0b013e3182197e38 · Cited by 21
Self-citationPolymorphisms in NR3C1 gene associated with risk of metabolic syndrome in a Chinese population
Yan, Y., Dong, J., Zhang, J., Liu, F., Wang, W., Zhang, L., & He, Y. (2014) · Endocrine · doi:10.1007/s12020-014-0324-9 · Cited by 18
Miura, M., Otani, K., & Ohkubo, T. (2005) · Xenobiotica · doi:10.1080/00498250500111612 · Cited by 18
Self-citationMarissal‐Arvy, N., Langlois, A., Tridon, C., & Mormède, P. (2010) · Metabolism · doi:10.1016/j.metabol.2010.07.005 · Cited by 18
Motoyama, S., Miura, M., Hinai, Y., Maruyama, K., Murata, K., & Ogawa, J. (2010) · World Journal of Surgery · doi:10.1007/s00268-010-0456-x · Cited by 13
Self-citationLipid disturbances before and after renal transplant.
Razeghi, E., Shafipour, M., Ashraf, H., & Pourmand, G. (2011) · PubMed · Cited by 11
Miura, M., Inoue, K., Kagaya, H., Saito, M., Habuchi, T., & Satoh, S. (2009) · Xenobiotica · doi:10.3109/00498250903294361 · Cited by 10
Self-citationHyperlipidemia after kidney transplantation: long-term graft outcome.
Raeesjalali, G., Eshraghian, A., Faghihi, A., Roozbeh, J., Sagheb, M. M., Eshraghian, H., & Behzadi, S. (2012) · Iranian Journal of Kidney Diseases · Cited by 8
DOSE-DEPENDENT REDUCTION OF BILE SECRETION IN CYCLOSPORINE-TREATED RATS
Mizuta, K., Kobayashi, E., Uchida, H., Fujimura, A., Kawarasaki, H., & Hashizume, K. (1998) · Transplantation · doi:10.1097/00007890-199803150-00030 · Cited by 5
Expression of the Peroxisome Proliferator-Activated Receptors (PPARs) in the Hepatic Stellate Cells
Sato, T., Sato, M., Miura, M., Higashi, N., Wang, D., Suzuki, S., Imai, K., Kojima, N., & Senoo, H. (2004) · Comparative Hepatology · doi:10.1186/1476-5926-2-s1-s17 · Cited by 3
Self-citation
Research works printed but not linked: 5
- 2004, American Journal of Transplantation, 4, 13
- 1998, Transplantation, 65, 758
- 2007, Journal of Atherosclerosis and Thrombosis, 5
- 2011, Experimental and Clinical Transplantation, 9, 230
- 2012, Iranian Journal of Kidney Diseases, 6, 49
Cited by
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz455 · Cited by 8,961
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.08.014 · Cited by 4,854
Dyslipidemia in Transplant Patients: Which Therapy?
Iannuzzo, G., Cuomo, G., Lorenzo, A. D., Tripaldella, M., Mallardo, V., Idelson, P. I., Sagnelli, C., Sica, A., Creta, M., Baltar, J., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11144080 · Cited by 33
Managing dyslipidemia in solid organ transplant patients
Mehta, A. (2024) · Indian Heart Journal · doi:10.1016/j.ihj.2024.01.004 · Cited by 14
Pathak, V., Madhavan, D., Narayanasamy, K., Kumar, S., Ramalingam, V., Sengodagounder, B., & Bodonyi-Kovacs, G. (2019) · Transplantation Direct · doi:10.1097/txd.0000000000000923 · Cited by 9
Metadata
- Authors
- Numakura, K., Kagaya, H., Yamamoto, R., Komine, N., Saito, M., Hiroshi, T., Akihama, S., Inoue, T., Narita, S., Tsuchiya, N., Habuchi, T., Niioka, T., Miura, M., & Satoh, S.
- Affiliations
- Akita University (JP)
- Akita University Hospital (JP)
- Department of Urology, Akita University Graduate School of Medicine, Akita 010-8543, Japan
- Corresponding author
- Numakura, Kazuyuki
- ORCID
- Venue
- Disease Markers
- Publisher
- Wiley
- Published
- 2015
- Volume
- 2015
- Pages
- 1-8
- ISSN
- 0278-0240 (ISSN-L)
- 1875-8630
- PMC
- PMC4402561
- OpenAlex
- W1994440963
- Cited by
- 14
- References
- 42
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2022: 4 · 2021: 1 · 2019: 3 · 2017: 1 · 2016: 1 · 2015: 1
- FWCI
- 0.82
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Disease Markers (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Japan Society for the Promotion of Science (15K15579)
- Topics
- Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Keywords
- dyslipidemia, kidney transplantation, kidney transplant recipients, genetic polymorphism, glucocorticoid receptor, NR3C1, mycophenolate mofetil, prednisolone, immunosuppressive therapy, sex differences, genetic risk factors, Japanese patients
- MeSH terms
- Adult, Aged, Female, Humans, Immunosuppressive Agents, Male, Middle Aged, Mycophenolic Acid, Prednisolone, Receptors, Glucocorticoid, Risk Factors, Sex Factors, Prevalence, Case-Control Studies, Kidney Transplantation, Polymorphism, Single Nucleotide, Dyslipidemias
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.